Skip to content
healthcare.dev

cholestyramine powder for suspension

NDC 67877-298, cholestyramine powder for suspension, powder, for suspension, from Ascend Laboratories, LLC.

Product NDC
67877-298
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211856
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-298 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHOLESTYRAMINE4 g/8.78g

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
67877-298-3767877029837368.76 g in 1 JAR (67877-298-37)
67877-298-606787702986060 POUCH in 1 CARTON (67877-298-60) / 8.78 g in 1 POUCH (67877-298-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/430ac07e-8524-4dec-a599-b7ebc56d9563
  • NADAC price for package 67877029837

    GET /v1/drugs/nadac/67877029837
  • NADAC price for package 67877029860

    GET /v1/drugs/nadac/67877029860

Use it

Look up 67877-298 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-298 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-298. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.